Disseminated Tuberculosis: Next Step in Management
Initiate immediate four-drug anti-tuberculosis therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, followed by rifampicin and isoniazid for an additional 10 months (total 12 months), while performing a lumbar puncture to exclude CNS involvement. 1
Immediate Actions Required
1. Perform Lumbar Puncture First
- Critical step: Disseminated/miliary TB has a high rate of blood-borne spread to the meninges 1
- If CNS involvement is confirmed or suspected, this determines treatment duration (12 months vs 6 months)
- Do not delay treatment while awaiting LP results if patient is critically ill
2. Initiate Standard Four-Drug Therapy Immediately
The regimen consists of:
- Rifampicin: 600 mg daily (>50 kg) or 450 mg daily (<50 kg)
- Isoniazid: 300 mg daily
- Pyrazinamide: 2.0 g daily (>50 kg) or 1.5 g daily (<50 kg)
- Ethambutol: 15 mg/kg daily 1
3. Pre-Treatment Screening (Do Not Delay Treatment)
Before starting therapy, obtain:
- Renal function: Required before ethambutol or streptomycin 1
- Liver function: Check AST/ALT and bilirubin 1
- Visual acuity: Snellen chart before ethambutol 1
- Inform patient to stop ethambutol immediately if visual symptoms occur
Treatment Duration Algorithm
If CNS involvement present (positive LP or clinical evidence):
- 2 months intensive phase: Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
- 10 months continuation phase: Rifampicin + Isoniazid
- Total: 12 months 1
If no CNS involvement:
- 2 months intensive phase: Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
- 4 months continuation phase: Rifampicin + Isoniazid
- Total: 6 months 1
Critical Monitoring During Treatment
Liver Function Monitoring
- If pre-existing liver disease: Weekly for 2 weeks, then every 2 weeks for first 2 months 1
- If normal baseline LFTs: Only repeat if fever, malaise, vomiting, jaundice, or unexplained deterioration occur 1
- Stop all hepatotoxic drugs if AST/ALT rises to 5× normal or bilirubin rises 1
If Patient is Critically Ill
- Consider inpatient treatment if unwell or sputum smear-positive 1
- If hepatotoxicity develops in critically ill patient, use streptomycin + ethambutol until liver function normalizes 1
Special Considerations for Disseminated TB
Corticosteroid Use
- Not routinely recommended for disseminated TB unless specific complications present
- Consider if pericardial involvement develops (60 mg/day initially, taper over weeks) 1
HIV Co-infection
- If patient is HIV-positive and on protease inhibitors: discontinue protease inhibitor and use alternative antiretrovirals until TB treatment completed 1
- Rifampicin induces CYP 3A P450, reducing protease inhibitor levels to potentially undetectable 1
Common Pitfalls to Avoid
- Do not wait for culture results to start treatment—disseminated TB has high mortality
- Do not omit the lumbar puncture—missing CNS involvement leads to inadequate treatment duration and poor outcomes
- Do not use twice-weekly dosing in disseminated disease—daily therapy is essential 2
- Do not forget pyridoxine (10 mg daily) if patient is diabetic, alcoholic, HIV-positive, has chronic renal failure, or is malnourished 1
Treatment Failure Indicators
If patient deteriorates or fails to improve after 2-4 weeks:
- Reassess for drug resistance
- Verify medication adherence
- Consider paradoxical reaction (may require corticosteroids)
- Evaluate for additional complications (pericarditis, meningitis progression)